For us, raising capital is about more than a transaction – it’s about being a committed partner throughout your company’s continued journey. We lead investment rounds and always invest ourselves in the companies we raise capital for. With extensive experience in investments and capital raising from family offices and VC firms in Sweden and Europe, we customise the setup to your needs – regardless of round size, stage, or investor type. Our commitment extends beyond the share issue, with a focus on creating long-term value and growth.
Through Sciety, you access investors who understand your business and share your ambition. Our network includes Nordic and European family offices, VC funds, corporate venture investors, and HNWIs, many with specialist expertise in life science. We’ll match your company with the right type of investor based on your stage, needs and profile, and help you tailor your message and investor materials to build strong investor relationships and long-term access to capital for future financing needs.
We know how critical time is to your development – every delay can affect patent windows, time to market, and competitive position. That’s why we work with a structured process, a dedicated team, and full focus on every engagement. To give each company our highest priority, we only work with a limited number of companies per year. To date, we have completed over 50 share issues, all successful.
Once the capital is in place, we continue to strengthen your company for the next step. By contributing industry expertise, connections, and increased visibility, we create the conditions for long-term growth. This may involve strengthening the board with relevant experience, opening doors to decision-makers, or creating visibility with new investors and potential buyers. Our goal is to increase your attractiveness ahead of future financing rounds, partnerships, or an exit.
“Partnering with Sciety in our capital raising was an effective way forward. Bringing a drug candidate from innovation to implementation requires capital, and thanks to Sciety we could continue this work without losing momentum. Sciety led the round with the highest professionalism and dedication, and their expertise in life science, business and finance was very useful. If you run a life science company and get the opportunity to work with Sciety, take it!”
Marika Nestor
CEO and Co-founder, Akiram Therapeutics
We know life science and we’re passionate about supporting companies that make a real difference. We also know that the road ahead requires more than capital. That’s why we continue to contribute even after the investment – with expertise, network, and experience to strengthen your development and growth.
“With Sciety’s support, we were able to recruit a new board member with solid, relevant experience in leading drug development projects, conducting licensing negotiations, and launching pharmaceuticals within our specific field – exactly the expertise we were looking for. This would not have been possible without Sciety’s extensive industry knowledge and well-established network in life science.”
Leo Holmgren
CEO, Pharmability
We invest in and raise capital for unlisted Nordic life science companies with the potential to become market leaders in their fields and make a real difference – for investors and for society. With deep specialist expertise and a strong network in life science and digital health, we contribute strategic support and capital for continued growth.
Your solution delivers concrete value in healthcare or research
Supported by data or research
With relevant experience and the drive to keep building
With the potential to expand geographically or across segments
The solution addresses an area with a clear and growing need
CASE STUDY | Capitainer, a medtech company specialising in at-home blood and urine sampling technologies, needed to raise external capital to make their vision a reality. The collaboration with Sciety resulted in an investment that enabled Capitainer to scale up production and increase sales. Capitainer’s long-term partnership with Sciety has also been pivotal in their strategic expansion into the US market.
From late preclinical phase to clinical phase II across all therapeutic areas.
From clinical validation to expansion phase. All indications.
From late preclinical phase to clinical phase II across all therapeutic areas.
From pilot phase to expansion phase. Services for research and healthcare.
From early sales to expansion phase. Healthcare and prevention.
Are you running a life science or health tech company with ambitious goals?
We partner with Nordic, unlisted companies that have a validated business model, a strong team, and a clear direction – and that are looking for a long-term partner for capital raising and value creation.
Email us at financing@sciety.se.
Attaching a pitch deck to your email is optional, but it helps us assess whether we’re a good match and speeds up our response.
